Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LAM RESEARCH CORPLRCX · Entity 1467 | Chief Executive Officer | May 22, 2018 | May 23, 2018 |
| QUALCOMM INC/DEQCOM · Entity 2852 | Director | October 08, 2018 | October 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LAM RESEARCH CORP
Report date May 22, 2018 · Filed May 23, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,259 |
Last balance in matching sequence
After 2018-05-22 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2018-05-22 · Exercise / conversion · Acquired 25,122 · Balance 154,381 F1: Amount reported includes shares subject to unvested Restricted Stock Units. Row 2 · 2018-05-22 · Sale · Disposed 3,285 · Balance 151,096 F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $202.32 to $203.31, inclusive. F1: Amount reported includes shares subject to unvested Restricted Stock Units. Row 3 · 2018-05-22 · Sale · Disposed 16,700 · Balance 134,396 F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $203.32 to $204.23, inclusive. F1: Amount reported includes shares subject to unvested Restricted Stock Units. Row 4 · 2018-05-22 · Sale · Disposed 5,137 · Balance 129,259 F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $204.33 to $205.19, inclusive. F1: Amount reported includes shares subject to unvested Restricted Stock Units. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.60 · Expires 2022-02-11 | Direct | 0 |
Reported balance
After 2018-05-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-05-22 · Exercise / conversion · Disposed 25,122 · Balance 0 F5: On 2/11/2015, the reporting person was granted stock options with a graded vesting schedule in which one-third of the total grant vested on each on 2/11/16, 2/11/17, and 2/11/18. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount reported includes shares subject to unvested Restricted Stock Units.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $202.32 to $203.31, inclusive.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $203.32 to $204.23, inclusive.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $204.33 to $205.19, inclusive.
F5: On 2/11/2015, the reporting person was granted stock options with a graded vesting schedule in which one-third of the total grant vested on each on 2/11/16, 2/11/17, and 2/11/18.
QUALCOMM INC/DE
Report date October 08, 2018 · Filed October 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 1,566 |
Reported balance
After 2018-10-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-10-08 · Grant · Acquired 1,566 · Balance 1,566 F1: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) April 5, 2021, (2) death, (3) disability, or (4) a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.
F2: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) April 5, 2021, (2) death, (3) disability, or (4) a change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2016 Filed Nov 29, 2016 18:29 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-16-000111 · wf-form4_148044416048949.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,290 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| March 01, 2016 Filed Mar 3, 2016 20:09 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 54,253 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-16-012213 · wf-form4_145703575625660.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,915 Underlying: Common Stock · 54,253 shares Expires not disclosed F4 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/19. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/1/16 to 2/1/19). F4 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/19. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/1/16 to 2/1/19). Read SEC document |
| March 01, 2016 Filed Mar 3, 2016 20:09 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 65,103 | $0.00 Strike: $75.57 | $0.00 |
DisclosureSEC source: 0001628280-16-012213 · wf-form4_145703575625660.xml · derivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,173 Underlying: Common Stock · 65,103 shares Expires 2023-03-01 F3 · derivative.exercise_date: 33.3% of the stock options will vest on 3/1/17, 3/1/18, and 3/1/19. Read SEC document |
| March 01, 2016 Filed Mar 3, 2016 20:09 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 32,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-16-012213 · wf-form4_145703575625660.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,867 F1 · shares: 33.3% of the RSUs will vest on 3/1/17, 3/1/18, and 3/1/19. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 22, 2016 Filed Feb 22, 2016 23:25 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 44,598 | $67.77 | $3,022,406.46 |
DisclosureSEC source: 0001628280-16-011501 · wf-form4_145618351558459.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 31,394 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/16. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. The performance payout was approved at 142.06% of target. The award vested on 2/18/16 and the shares were distributed on 2/22/16. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 22, 2016 Filed Feb 24, 2016 00:58 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 23,271 | $67.77 | $1,577,075.67 |
DisclosureSEC source: 0001628280-16-011610 · wf-form4_145627550990281.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,315 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 23:25 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionMarket-based Performance Restricted Stock Unit · Derivative | 31,394 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-16-011501 · wf-form4_145618351558459.xml · derivative · entry 4 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,662 Underlying: Common Stock · 31,394 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On 2/18/14, the Reporting Person received a target grant of 31,394 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 2/18/16. The performance of this award was based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. The performance payout was approved at 142.06% of target. The award vested on 2/18/16 and the shares were distributed on 2/22/16. F3 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/18/14 to 2/17/16). F3 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of (2/18/14 to 2/17/16). Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 23:25 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 8,737 | $67.77 | $592,106.49 |
DisclosureSEC source: 0001628280-16-011501 · wf-form4_145618351558459.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,988 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 23:25 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 12,495 | $67.77 | $846,786.15 |
DisclosureSEC source: 0001628280-16-011501 · wf-form4_145618351558459.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,725 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 11, 2016 Filed Feb 17, 2016 00:21 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 4,194 | $64.21 | $269,296.74 |
DisclosureSEC source: 0001628280-16-011271 · wf-form4_145566847922414.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,220 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 26, 2015 Filed Oct 27, 2015 21:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 7,948 | $73.90 | $587,325.41 |
DisclosureSEC source: 0001631209-15-000001 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,414 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.50 to $74.68, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| August 03, 2015 Filed Aug 5, 2015 17:27 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 7,948 | $76.19 | $605,526.33 |
DisclosureSEC source: 0001192381-15-000027 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,362 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.77 to $76.64, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 19:03 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 2,096 | $77.45 | $162,328.91 |
DisclosureSEC source: 0001192381-15-000025 · primary_doc.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,961 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.22 to $77.69, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 19:03 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 5,911 | $76.68 | $453,255.48 |
DisclosureSEC source: 0001192381-15-000025 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,057 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.21 to $77.20, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,557 | $0.00 Strike: $51.76 | $0.00 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · derivative · entry 7 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,070 Underlying: Common Stock · 12,557 shares Expires 2021-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 33.3% of the stock options will vest on 2/18/15, 2/18/16 and 2/18,17. Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 88,005 | $0.00 Strike: $42.61 | $0.00 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · derivative · entry 6 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,627 Underlying: Common Stock · 88,005 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 12,557 | $82.15 | $1,031,544.99 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · nonDerivative · entry 5 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,968 F2 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.08 - $82.35, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 12,557 | $51.76 | $649,950.32 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · nonDerivative · entry 4 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 88,005 | $81.80 | $7,198,368.98 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,968 F2 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.43 - $82.08, inclusive. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 88,005 | $42.61 | $3,749,893.05 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 22:10 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 8,736 | $81.92 | $715,653.12 |
DisclosureSEC source: 0001192381-15-000018 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,968 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| February 11, 2015 Filed Feb 13, 2015 22:21 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 41,873 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001192381-15-000012 · primary_doc.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,056 Underlying: Common Stock · 41,873 shares Expires not disclosed F4 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/2/18. F4 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/2/18. Read SEC document |
| February 11, 2015 Filed Feb 13, 2015 22:21 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 25,122 | $0.00 Strike: $80.60 | $0.00 |
DisclosureSEC source: 0001192381-15-000012 · primary_doc.xml · derivative · entry 2 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,632 Underlying: Common Stock · 25,122 shares Expires 2022-02-11 F3 · derivative.exercise_date: 33.3% of the stock options will vest on 2/11/16, 2/11/17, and 2/11/18. Read SEC document |
| February 11, 2015 Filed Feb 13, 2015 22:21 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 33,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-15-000012 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,704 F1 · shares: 33.3% of the RSUs will vest on 2/11/16, 2/11/17, and 2/11/18. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 06, 2015 Filed Feb 10, 2015 20:20 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 13,439 | $78.14 | $1,050,123.46 |
DisclosureSEC source: 0001192381-15-000002 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,206 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| November 05, 2014 Filed Nov 8, 2014 00:04 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GiftCommon Stock | 1,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000036 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,645 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| April 03, 2014 Filed Apr 4, 2014 22:30 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 13,350 | $57.90 | $772,965.00 |
DisclosureSEC source: 0001192381-14-000024 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,246 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 22:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 31,394 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000009 · primary_doc.xml · derivative · entry 6 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,183 Underlying: Common Stock · 31,394 shares Expires not disclosed F7 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. F7 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/16. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/16. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 22:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantMarket-based Performance Restricted Stock Unit · Derivative | 62,789 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000009 · primary_doc.xml · derivative · entry 5 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,789 Underlying: Common Stock · 62,789 shares Expires not disclosed F6 · derivative.exercise_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/17. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. F6 · derivative.expiration_date: These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/18/17. The performance of these awards is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/18/14 to 2/17/17. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 22:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 18,834 | $0.00 Strike: $51.76 | $0.00 |
DisclosureSEC source: 0001192381-14-000009 · primary_doc.xml · derivative · entry 4 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,510 Underlying: Common Stock · 18,834 shares Expires 2021-02-18 F5 · derivative.exercise_date: 100% of the stock options will vest on 2/18/16. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 22:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantEmployee Stock Option (Right to Buy) · Derivative | 37,671 | $0.00 Strike: $51.76 | $0.00 |
DisclosureSEC source: 0001192381-14-000009 · primary_doc.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,676 Underlying: Common Stock · 37,671 shares Expires 2021-02-18 F4 · derivative.exercise_date: 33.3% of the stock options will vest on 2/18/15, 2/18/16 and 2/18/17. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 22:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 25,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000009 · primary_doc.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,596 F2 · shares: 100% of the RSUs will vest on 2/18/16. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 22:39 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 50,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001192381-14-000009 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,481 F1 · shares: 33.3% of the RSUs will vest on 2/18/15, 2/18/16 and 2/18/17. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 07, 2014 Filed Feb 20, 2014 18:01 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 18,251 | $51.85 | $946,314.35 |
DisclosureSEC source: 0001192381-14-000008 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,250 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 24, 2013 Filed Oct 29, 2013 00:08 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 9,442 | $54.94 | $518,743.48 |
DisclosureSEC source: 0001192381-13-000014 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,501 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| July 11, 2013 Filed Jul 15, 2013 18:38 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionStock Option (right to buy) · Derivative | 29,120 | $20.21 Strike: $20.21 | $588,515.20 |
DisclosureSEC source: 0001501289-13-000032 · primary_doc.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,005 Underlying: Common Stock · 29,120 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2013 Filed Jul 15, 2013 18:38 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 29,120 | $50.02 | $1,456,436.80 |
DisclosureSEC source: 0001501289-13-000032 · primary_doc.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,943 F1 · shares: Shares sold pursuant to 10b5-1 Trading Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 - $50.14, inclusive. F3 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| July 11, 2013 Filed Jul 15, 2013 18:38 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 29,120 | $20.21 | $588,515.20 |
DisclosureSEC source: 0001501289-13-000032 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2013 Filed Mar 6, 2013 23:53 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,372 | $42.59 | $228,793.48 |
DisclosureSEC source: 0001501289-13-000017 · primary_doc.xml · nonDerivative · entry 3 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,200 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units Read SEC document |
| March 04, 2013 Filed Mar 6, 2013 23:53 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 4,963 | $42.59 | $211,374.17 |
DisclosureSEC source: 0001501289-13-000017 · primary_doc.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 04, 2013 Filed Mar 6, 2013 23:53 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Disposition to issuerCommon Stock | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001501289-13-000017 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 08, 2013 Filed Feb 12, 2013 22:49 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantStock Option (right to buy) · Derivative | 88,005 | $42.61 Strike: $42.61 | $3,749,893.05 |
DisclosureSEC source: 0001501289-13-000013 · primary_doc.xml · derivative · entry 2 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,125 Underlying: Common Stock · 88,005 shares Expires 2020-02-08 F1 · derivative.exercise_date: 100% of the option will vest and become exercisable on 02/08/15. Read SEC document |
| February 08, 2013 Filed Feb 12, 2013 22:49 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 29,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001501289-13-000013 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,318 F2 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| February 07, 2012 Filed Feb 10, 2012 01:24 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 40,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001501289-12-000021 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,300 Read SEC document |
| February 06, 2012 Filed Feb 8, 2012 23:07 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 6,232 | $43.23 | $269,409.36 |
DisclosureSEC source: 0001501289-12-000017 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,959 Read SEC document |
| February 05, 2012 Filed Feb 7, 2012 22:19 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Tax withholdingCommon Stock | 5,577 | $44.19 | $246,447.63 |
DisclosureSEC source: 0001501289-12-000010 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,191 Read SEC document |
| June 01, 2011 Filed Jun 2, 2011 22:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $20.21 Strike: $20.21 | $303,150.00 |
DisclosureSEC source: 0001293332-11-000004 · primary_doc.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,120 Underlying: Common Stock · 15,000 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2011 Filed Jun 2, 2011 22:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | SaleCommon Stock | 15,000 | $48.00 | $720,000.00 |
DisclosureSEC source: 0001293332-11-000004 · primary_doc.xml · nonDerivative · entry 2 Anstice Martin B · CIK 0001293332 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,768 Read SEC document |
| June 01, 2011 Filed Jun 2, 2011 22:35 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionCommon Stock | 15,000 | $20.21 | $303,150.00 |
DisclosureSEC source: 0001293332-11-000004 · primary_doc.xml · nonDerivative · entry 1 Anstice Martin B · CIK 0001293332 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2011 Filed May 12, 2011 18:13 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $20.21 Strike: $20.21 | $202,100.00 |
DisclosureSEC source: 0001293332-11-000003 · primary_doc.xml · derivative · entry 3 Anstice Martin B · CIK 0001293332 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,120 Underlying: Common Stock · 10,000 shares Expires 2014-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.